Ovarian Granulosa-Stromal Cell Tumor — Trials

Ovarian Granulosa-Stromal Cell Tumor — Trials · CancerIndex

Clinical trials

Registered studies

7 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–7 of 7 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05348356	Nirogacestat in Ovarian Granulosa Cell Tumors	completed	Phase 2	53	SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, GermanyINDUSTRY	3	Aug 25, 2026	clinicaltrials
NCT06169124	Study to Test the Drug Darolutamide Along With the Drugs Leuprolide Acetate and Exemestane in Patients With Recurrent Ovarian Granulosa Cell Tumors	active not recruiting	Phase 2	17	National Cancer Institute (NCI)NIH	1	Jul 28, 2026	clinicaltrials
NCT06254781	Luspatercept in Metastatic AGCT of the Ovary	completed	N/A	1	University Health Network, TorontoOTHER	1	Feb 12, 2024	clinicaltrials
NCT01042522

Data updated 22 days agoSource updated Aug 25, 2026source: clinicaltrials